Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Generini

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|December 22, 1999
Raynaud's phenomenon and vascular disease in systemic sclerosisS Generini, M Matucci Cerinic
Clinical and Experimental Rheumatology|September 1, 1993
Iliopsoas bursitis in rheumatoid arthritisS Generini, M Matucci-Cerinic
Clinical and Experimental Rheumatology|December 5, 2002
Therapy of spondylarthropathy in inflammatory bowel diseaseS Generini, G Fiori, M Matucci Cerinic
Current Opinion in Rheumatology|February 12, 1998
New approaches to Raynaud's phenomenon [corrected]M M Cerinic, S Generini, A Pignone
Clinical and Experimental Rheumatology|June 16, 2001
Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosisA Pignone, S Generini, M Matucci Cerinic
Rheumatic Diseases Clinics of North America|November 1, 1996
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanismsM M Cerinic, S Generini, A Pignone, et al.
Chest|February 15, 2001
The loss of endothelium-dependent vascular tone control in systemic sclerosisR Livi, L Teghini, S Generini, et al.
Lancet (London, England)|November 30, 2000
NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritisM Tuveri, S Generini, M Matucci-Cerinic, et al.
Clinics in Dermatology|December 11, 1999
Vasculitides secondary to systemic diseasesA Del Rosso, S Generini, A Pignone, et al.
Clinical and Experimental Rheumatology|March 23, 2000
Can fibroblasts determine the late differing outcome between systemic sclerosis and primary hypertrophic osteoarthropathy (pachydermoperiostosis)?M Matucci-Cerinic, A Pignone, S Generini, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|December 22, 1999
Raynaud's phenomenon and vascular disease in systemic sclerosisS Generini, M Matucci Cerinic
Clinical and Experimental Rheumatology|September 1, 1993
Iliopsoas bursitis in rheumatoid arthritisS Generini, M Matucci-Cerinic
Clinical and Experimental Rheumatology|December 5, 2002
Therapy of spondylarthropathy in inflammatory bowel diseaseS Generini, G Fiori, M Matucci Cerinic
Current Opinion in Rheumatology|February 12, 1998
New approaches to Raynaud's phenomenon [corrected]M M Cerinic, S Generini, A Pignone
Clinical and Experimental Rheumatology|June 16, 2001
Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosisA Pignone, S Generini, M Matucci Cerinic
Rheumatic Diseases Clinics of North America|November 1, 1996
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanismsM M Cerinic, S Generini, A Pignone, et al.
Chest|February 15, 2001
The loss of endothelium-dependent vascular tone control in systemic sclerosisR Livi, L Teghini, S Generini, et al.
Lancet (London, England)|November 30, 2000
NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritisM Tuveri, S Generini, M Matucci-Cerinic, et al.
Clinics in Dermatology|December 11, 1999
Vasculitides secondary to systemic diseasesA Del Rosso, S Generini, A Pignone, et al.
Clinical and Experimental Rheumatology|March 23, 2000
Can fibroblasts determine the late differing outcome between systemic sclerosis and primary hypertrophic osteoarthropathy (pachydermoperiostosis)?M Matucci-Cerinic, A Pignone, S Generini, et al.
Pageof 5